ARCHIVES

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

Researchers Identify Subtype Demonstrating Angiogenesis

February 24, 2012

NCI Posts Website Usability Research, Information Online.

January 12, 2001

High Radiation Dose Effective Ten Years After Treatment

November 28, 2003

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008

Executive Summary of Centers, SPOREs Report

February 28, 2003

With A Flat Budget, Niederhuber Outlines NCI Priorities In Speech To ASCO Meeting.

June 13, 2008